Providing a comprehensive range of therapeutic proteins derived from plasma and through innovative recombinant technology. These high-quality, leading therapies are used to enhance the lives of patients requiring support for hemostasis, immune deficiencies, Alpha1-PI deficiency, and hemophilia and other blood-related disorders.